KFDA to review 911 drugs including 61 GSK products.

The KFDA reported in "The status of new drugs and others to review" that the total 911 drugs should be reviewed, of which GSK had the highest number of products including Avandia, an anti-diabetic drug, among the foreign multinational drug companies and Dong-A and Choongwae among the domestic industries.

It was also reported that 36 drugs of review completion included Yuhan's Revaprazan (Re...